Literature Citations
1. Synthesis of New Cyanopyridine Scaffolds and Their Biological Activities. Alhakamy, N.A., A.O. Noor, K.M. Hosny, J.J. Nasr, M.M.G. Fouda, T.A. Khattab, and H.E. Gaffer. Current Organic Synthesis, 2020. 17(7): p. 567-575. PMID[32600235].
[PubMed]. TB_12_2020.
2. Antitubercular and Antiparasitic 2-Nitroimidazopyrazinones with Improved Potency and Solubility. Ang, C.W., L. Tan, M.L. Sykes, N. AbuGharbiyeh, A. Debnath, J.C. Reid, N.P. West, V.M. Avery, M.A. Cooper, and M.A.T. Blaskovich. Journal of Medicinal Chemistry, 2020. 63(24): p. 15726-15751. PMID[33151678]. PMCID[PMC7770830].
[PubMed]. TB_12_2020.
3. 6-Nitro-1-benzylquinolones Exhibiting Specific Antitubercular Activity. Beteck, R.M., A. Jordaan, T. Swart, F. Van Der Kooy, D.F. Warner, H.C. Hoppe, and L.J. Legoabe. Chemical Biology & Drug Design, 2020. 96(6): p. 1387-1394. PMID[32558257].
[PubMed]. TB_12_2020.
4. Sulfamic acid Catalyzed Synthesis of New 3,5-[(Sub)phenyl]-1H-pyrazole Bearing N(1)-Isonicotinoyl: and Their Pharmacological Activity Evaluation. Bhirud, J.D., R.D. Patil, and H.P. Narkhede. Bioorganic & Medicinal Chemistry Letters, 2020. 30(23): 127558. PMID[32961321].
[PubMed]. TB_12_2020.
5. Biological Profiling Enables Rapid Mechanistic Classification of Phenotypic Screening Hits and Identification of KatG Activation-dependent Pyridine Carboxamide Prodrugs with Activity against Mycobacterium tuberculosis. Chengalroyen, M.D., A. Jordaan, R. Seldon, T. Ioerger, S.G. Franzblau, M. Nasr, D.F. Warner, and V. Mizrahi. Frontiers in Cellular and Infection Microbiology, 2020. 10: p. 582416. PMID[33282750]. PMCID[PMC7691319].
[PubMed]. TB_12_2020.
6. Synthesis and Biological Evaluation of Anti-tubercular Activity of Schiff Bases of 2-Amino thiazoles. Cordeiro, R. and M. Kachroo. Bioorganic & Medicinal Chemistry Letters, 2020. 30(24): 127655. PMID[33130292].
[PubMed]. TB_12_2020.
7. Phenanthrolinic Analogs of Quinolones Show Antibacterial Activity against M. tuberculosis. Coulibaly, S., M. Cimino, M. Ouattara, C. Lecoutey, M.V. Buchieri, N. Alonso-Rodriguez, J. Briffotaux, D. Mornico, B. Gicquel, C. Rochais, and P. Dallemagne. European Journal of Medicinal Chemistry, 2020. 207: 112821. PMID[32950907].
[PubMed]. TB_12_2020.
8. Chemical Composition and in Vitro Antibacterial Activity of Essential Oils from Murraya paniculata (L.) Jack (Rutaceae) Ripe and Unripe Fruits against Bacterial Genera Mycobacterium and Streptococcus. da Silva, F.F.A., C.C. Fernandes, M.B. Santiago, C.H.G. Martins, T.M. Vieira, A.E.M. Crotti, and M.L.D. Miranda. Brazilian Journal of Pharmaceutical Sciences, 2020. 56: e18371. ISI[000592261800001].
[WOS]. TB_12_2020.
9. New One-pot Synthesis of anti-Tuberculosis Compounds Inspired on Isoniazid. Ghiano, D.G., A. Recio-Balsells, A. Bortolotti, L.A. Defelipe, A. Turjanski, H.R. Morbidoni, and G.R. Labadie. European Journal of Medicinal Chemistry, 2020. 208: 112699. PMID[32927391].
[PubMed]. TB_12_2020.
10. One-pot Synthesis and Docking Study of New Pyranopyrazole Derivatives as Potent Antimicrobial Agents. Hallikeri, C.S., R. Patil, S.R.P. Kumar, V.H. Kulkarni, and S.D. Joshi. Indian Journal of Heterocyclic Chemistry, 2020. 30(2): p. 223-232. ISI[000589507900013].
[WOS]. TB_12_2020.
11. Discovery of Thienothiazolocarboxamide Analogues as Novel Anti-tubercular Agent. Jin, G., Y. Mi Kim, A. Lee, J. Choi, S. Kang, M. Seo, J. Jea Seo, S. Lee, J. Kang, J. Kim, S. Park, M. Woo, V.C.A. Falcao, H. Lee, J. Heo, D. Shum, K. Park, V. Delorme, and I. Choi. Bioorganic & Medicinal Chemistry, 2020. 28(23): 115797. PMID[33075682].
[PubMed]. TB_12_2020.
12. Palladium-catalysed Synthesis of Arylnaphthoquinones as Antiprotozoal and Antimycobacterial Agents. Kalt, M.M., W. Schuehly, R. Saf, S. Ochensberger, J. Solnier, F. Bucar, M. Kaiser, and A. Presser. European Journal of Medicinal Chemistry, 2020. 207: 112837. PMID[33002847].
[PubMed]. TB_12_2020.
13. New Application of 1,2,4-Triazole Derivatives as Antitubercular Agents. Structure, in Vitro Screening and Docking Studies. Karczmarzyk, Z., M. Swatko-Ossor, W. Wysocki, M. Drozd, G. Ginalska, A. Pachuta-Stec, and M. Pitucha. Molecules, 2020. 25(24): 6033. PMID[33352814]. PMCID[PMC7767103].
[PubMed]. TB_12_2020.
14. Copper(I) and Silver(I) Complexes of Anthraldehyde thiosemicarbazone: Synthesis, Structure Elucidation, in Vitro Anti-tuberculosis/Cytotoxic Activity and Interactions with DNA/HSA. Khan, A., K. Paul, I. Singh, J.P. Jasinski, V.A. Smolenski, E.P. Hotchkiss, P.T. Kelley, Z.A. Shalit, M. Kaur, S. Banerjee, P. Roy, and R. Sharma. Dalton Transactions, 2020. 49(47): p. 17350-17367. PMID[33210698].
[PubMed]. TB_12_2020.
15. Design, Synthesis and Evaluation of Covalent Inhibitors of DprE1 as Antitubercular Agents. Liu, L., C. Kong, M. Fumagalli, K. Savkova, Y. Xu, S. Huszar, J.C. Sammartino, D. Fan, L.R. Chiarelli, K. Mikusova, Z. Sun, and C. Qiao. European Journal of Medicinal Chemistry, 2020. 208: 112773. PMID[32898793].
[PubMed]. TB_12_2020.
16. Synthesis of Novel 4,5-Dihydropyrrolo[1,2-a]quinoxalines, Pyrrolo[1,2-a]quinoxalin]-2-ones and Their Antituberculosis and Anticancer Activity. Makane, V.B., E. Vamshi Krishna, U.B. Karale, D.A. Babar, S. Kalari, E.M. Rekha, M. Shukla, G. Kaul, D. Sriram, S. Chopra, S. Misra, and H.B. Rode. Archiv der Pharmazie, 2020. 353(12): e2000192. PMID[32786042].
[PubMed]. TB_12_2020.
17. Synthesis and Evaluation of Thiophene Based Small Molecules as Potent Inhibitors of Mycobacterium tuberculosis. Meena, C.L., P. Singh, R.P. Shaliwal, V. Kumar, A. Kumar, A.K. Tiwari, S. Asthana, R. Singh, and D. Mahajan. European Journal of Medicinal Chemistry, 2020. 208: 112772. PMID[32920342].
[PubMed]. TB_12_2020.
18. Synthesis of 2-Chloro-N-(4-(6-chloroH-imidazo 1,2-a pyridin-2-Yl)phenyl) acetamide Derivatives as Antitubercular Agents. Nadaf, A.A., S. Gaonkar, S. Mantur, M.S. Najare, M. Yaseen, M.G. Sunagar, S. Joshi, and I.A.M. Khazi. ChemistrySelect, 2020. 5(45): p. 14422-14429. ISI[000596036800026].
[WOS]. TB_12_2020.
19. Novel Pyrazole-clubbed Thiophene Derivatives via Gewald Synthesis as Antibacterial and Anti-inflammatory Agents. Nayak, S.G., B. Poojary, and V. Kamat. Archiv der Pharmazie, 2020. 353(12): e2000103. PMID[32893908].
[PubMed]. TB_12_2020.
20. Design, Synthesis, and Biological Evaluation of Novel Imidazo[1,2-a]pyridinecarboxamides as Potent anti-Tuberculosis Agents. Onajole, O.K., S. Lun, Y.J. Yun, D.Y. Langue, M. Jaskula-Dybka, A. Flores, E. Frazier, A.C. Scurry, A. Zavala, K.R. Arreola, B. Pierzchalski, A.J. Ayitou, and W.R. Bishai. Chemical Biology and Drug Design, 2020. 96(6): p. 1362-1371. PMID[32515129].
[PubMed]. TB_12_2020.
21. Novel Isoniazid-carborane Hybrids Active in Vitro against Mycobacterium tuberculosis. Rozycka, D., M. Korycka-Machala, A. Zaczek, J. Dziadek, D. Gurda, M. Orlicka-Plocka, E. Wyszko, K. Biniek-Antosiak, W. Rypniewski, and A.B. Olejniczak. Pharmaceuticals, 2020. 13(12): 465. PMID[33333865]. PMCID[PMC7765321].
[PubMed]. TB_12_2020.
22. Structure-based Discovery of Narirutin as a Shikimate kinase Inhibitor with Anti-tubercular Potency. Sahu, P.K., P.K. Mohapatra, D.P. Rajani, and M.K. Raval. Current Computer-Aided Drug Design, 2020. 16(5): p. 523-529. PMID[31654517].
[PubMed]. TB_12_2020.
23. Biochemical Characterization of ClpB Protein from Mycobacterium tuberculosis and Identification of Its Small-molecule Inhibitors. Singh, P., H. Khurana, S.P. Yadav, K. Dhiman, P. Singh, Ashish, R. Singh, and D. Sharma. International Journal of Biological Macromolecules, 2020. 165(Pt A): p. 375-387. PMID[32987071].
[PubMed]. TB_12_2020.
24. Trypethelone and Phenalenone Derivatives Isolated from the Mycobiont Culture of Trypethelium eluteriae Spreng. and Their Anti-mycobacterial Properties. Srinivasan, M., K. Shanmugam, B. Kedike, S. Narayanan, S. Shanmugam, and H. Gopalasamudram Neelakantan. Natural Product Research, 2020. 34(23): p. 3320-3327. PMID[30798639].
[PubMed]. TB_12_2020.
25. High-throughput Screening to Discover Inhibitors of the CarD.RNA Polymerase Protein-protein Interaction in Mycobacterium tuberculosis. Stefan, M.A., G.M. Velazquez, and G.A. Garcia. Scientific Reports, 2020. 10(1): 21309. PMID[33277558]. PMCID[PMC7718890].
[PubMed]. TB_12_2020.
26. Bioactive Compounds from the Bornean Endemic Plant Goniothalamus longistipetes. Teo, S.P., S. Bhakta, P. Stapleton, and S. Gibbons. Antibiotics, 2020. 9(12): 913. PMID[33339285]. PMCID[PMC7767169].
[PubMed]. TB_12_2020.
27. Design, Synthesis, Antimycobacterial Activity and Molecular Docking Studies of Novel 3- (N-substituted glycinamido) benzoic acid Analogues as Anti Tubercular Agents. Veeravarapu, H., M. Tirumalasetty, S. Kurati, U. Wunnava, and M. Krishna Kumar Muthyala. Bioorganic & Medicinal Chemistry Letters, 2020. 30(23): 127603. PMID[33039564].
[PubMed]. TB_12_2020.
28. 1,3-Oxazine-2-one Derived Dual-targeted Molecules against Replicating and Non-replicating Forms of Mycobacterium tuberculosis. Velappan, A.B., D. Kesamsetty, D. Datta, R. Ma, N. Hari, S.G. Franzblau, and J. Debnath. European Journal of Medicinal Chemistry, 2020. 208: 112835. PMID[32977201].
[PubMed]. TB_12_2020.
29. TB47 and Clofazimine Form a Highly Synergistic Sterilizing Block in a Second-line Regimen for Tuberculosis in Mice. Yu, W., G. Chiwala, Y. Gao, Z. Liu, S. Sapkota, Z. Lu, L. Guo, S.A. Khan, N. Zhong, and T. Zhang. Biomedicine and Pharmacotherapy, 2020. 131: 110782. PMID[33152940].
[PubMed]. TB_12_2020.
30. A Protein Fragment of Rv3194c Located on Mycobacterial Cell Surface Efficiently Prevents Adhesion of Recombinant Mycobacterium smegmatis, and Promises a New Anti-adhesive Drug. Zhao, D., D. Lin, and C. Xu. Microbial Pathogenesis, 2020. 149: 104498. PMID[32931894].
[PubMed]. TB_12_2020.
Patent Citations
31. Novel Aryloxazolidinone Compounds for the Treatment of Mammalian Infections and Their Preparation. Desai, R., V. Pandya, A. Satyanand, B. Vora, J. Joshi, M. Pujara, and A. Argade. Patent. 2020. 2019-IB60511 2020234636: 74pp.
[Patent]. TB_12_2020.